Company name | Market Cap | Growth score | Revenue Growth
(5Y CAGR) | Revenue Growth
(YoY) | Revenue Growth
(FWD) | EPS Growth
(5Y CAGR) | EPS Growth
(YoY) | EPS Growth
(FWD) | FCF Growth
(5Y CAGR) | FCF Growth
(YoY) |
$175.6B | 5.6 | 7.4% | 18.2% | 3.2% | (10.1%) | (39.3%) | 175.6% | 4.0% | 41.2% | |
$785.8B | 8.0 | 15.1% | 32.0% | 29.8% | 6.2% | 106.1% | 91.1% | N/A | (93.2%) | |
$401.2B | 3.7 | 1.6% | 4.3% | 2.4% | (3.2%) | (58.1%) | 80.7% | (1.9%) | (1.0%) | |
$378.3B | 4.9 | 11.1% | 3.7% | 5.0% | (14.6%) | (11.7%) | 404.4% | 6.9% | (19.2%) | |
$240.9B | 8.6 | 17.3% | 18.0% | 5.4% | 28.4% | (6.3%) | 3.0% | 70.2% | 10.8% | |
$240.5B | 7.0 | 0.7% | (19.2%) | 6.4% | 11.9% | 4,406.7% | 5,382.2% | 9.3% | 70.4% | |
$229.6B | 6.1 | 1.0% | 0.1% | 1.0% | 3.0% | (17.7%) | 37.6% | 4.0% | 19.8% | |
$151.5B | 5.1 | 4.2% | 8.8% | (1.1%) | (13.5%) | 272.8% | 103.4% | (16.6%) | (15.9%) | |
$148.5B | 5.2 | 3.3% | (22.5%) | N/A | 20.9% | 3.0% | N/A | N/A | N/A | |
$146.5B | 5.5 | 5.1% | 6.0% | (1.0%) | (38.3%) | (91.6%) | 1,890.4% | 4.7% | 40.8% | |
$124.0B | 6.9 | 13.1% | 7.3% | (3.5%) | N/A | N/A | (258.3%) | 14.0% | 10.2% |
The Amgen Inc. (AMGN) revenue growth is 18.2%, which is lower than the industry median of 4.0% and the 5-year historical average of 6.2%.
The Amgen Inc. (AMGN) operating income growth is (21.1%), compared to the industry median of 10.0% and the 5-year historical average of (6.1%).
The Amgen Inc. (AMGN) EPS growth is (39.3%), compared to the industry median of (11.7%) and the 5-year historical average of (6.7%).
The Amgen Inc. (AMGN) Free Cash Flow growth is 41.2%, compared to the industry median of 10.8% and the 5-year historical average of (2.9%).